Study Summary
This trial is testing whether two different tests can show why patients who have had a kidney transplant and have developed antibodies against their donor are at a greater risk for their transplanted organ being rejected.
Treatment Effectiveness
Effectiveness Progress
Similar Trials
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: Post bone marrow collection
Post bone marrow collection
To determine the variability of the AlloElispot and Allospecificities assay.
Trial Safety
Safety Progress
Similar Trials
Trial Design
1 Treatment Group
Sensitized Renal Allograft Recipients
1 of 1
Experimental Treatment
80 Total Participants · 1 Treatment Group
Primary Treatment: bone marrow aspirations · No Placebo Group · N/A
Sensitized Renal Allograft Recipients
Procedure
Experimental Group · 1 Intervention: bone marrow aspirations · Intervention Types: ProcedureTrial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: post bone marrow collection
Who is running the clinical trial?
Mark StegallLead Sponsor
3 Previous Clinical Trials
1,235 Total Patients Enrolled
Mayo ClinicLead Sponsor
2,922 Previous Clinical Trials
3,517,073 Total Patients Enrolled
Mark Stegall, MDPrincipal Investigator - Mayo Clinic
Mayo Clinic Hospital-Rochester Saint Marys Campus
Columbia University College Of Physicians And Surgeons (Medical School)
University Of Wi Hosp & Cli (Residency)
4 Previous Clinical Trials
310 Total Patients Enrolled
Eligibility Criteria
Age 18 - 99 · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments